Literature DB >> 33523449

The Association of Gut Microbiota and Treg Dysfunction in Autoimmune Diseases.

Yuying Liu1, Dat Q Tran1, John William Lindsey2, Jon Marc Rhoads3.   

Abstract

Autoimmune conditions affect 23 million Americans or 7% of the US population. There are more than 100 autoimmune disorders, affecting every major organ system in humans. This chapter aims to further explain Treg dysfunction autoimmune disorders, including monogenic primary immune deficiency such as immune dysregulation polyendocrinopathy, enteropathy, X-linked inheritance (IPEX) syndrome, and polygenic autoimmune diseases with Treg dysfunction such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and food allergy. These conditions are associated with an abnormal small intestinal and colonic microbiome. Some disorders clearly improve with therapies aimed at microbial modification, including probiotics and fecal microbiota transplantation (FMT). Approaches to prevent and treat these disorders will need to focus on the acquisition and maintenance of a healthy colonic microbiota, in addition to more focused approaches at immune suppression during acute disease exacerbations.

Entities:  

Keywords:  Dysbiosis; Immunodeficiency; Inflammatory bowel disease; Multiple sclerosis; Probiotic

Mesh:

Year:  2021        PMID: 33523449      PMCID: PMC9290759          DOI: 10.1007/978-981-15-6407-9_10

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   3.650


  76 in total

Review 1.  Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host.

Authors:  Vadivel Ganapathy; Muthusamy Thangaraju; Puttur D Prasad; Pamela M Martin; Nagendra Singh
Journal:  Curr Opin Pharmacol       Date:  2013-08-23       Impact factor: 5.547

2.  Lactobacillus reuteri DSM 17938 feeding of healthy newborn mice regulates immune responses while modulating gut microbiota and boosting beneficial metabolites.

Authors:  Yuying Liu; Xiangjun Tian; Baokun He; Thomas K Hoang; Christopher M Taylor; Eugene Blanchard; Jasmin Freeborn; Sinyoung Park; Meng Luo; Jacob Couturier; Dat Q Tran; Stefan Roos; Guoyao Wu; J Marc Rhoads
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-09-04       Impact factor: 4.052

3.  Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease.

Authors:  Robert P Hirten; Ari Grinspan; Shih-Chen Fu; Yuying Luo; Mayte Suarez-Farinas; John Rowland; Eduardo J Contijoch; Ilaria Mogno; Nancy Yang; Tramy Luong; Philippe R Labrias; Inga Peter; Judy H Cho; Bruce E Sands; Jean Frederic Colombel; Jeremiah J Faith; Jose C Clemente
Journal:  Inflamm Bowel Dis       Date:  2019-05-04       Impact factor: 5.325

4.  Gastrointestinal Autoimmunity Associated With Loss of Central Tolerance to Enteric α-Defensins.

Authors:  Jan Dobeš; Aleš Neuwirth; Martina Dobešová; Matouš Vobořil; Jana Balounová; Ondřej Ballek; Jan Lebl; Antonella Meloni; Kai Krohn; Nicolas Kluger; Annamari Ranki; Dominik Filipp
Journal:  Gastroenterology       Date:  2015-05-15       Impact factor: 22.682

Review 5.  Induction of regulatory T cells: A role for probiotics and prebiotics to suppress autoimmunity.

Authors:  Mitesh Dwivedi; Prasant Kumar; Naresh C Laddha; E Helen Kemp
Journal:  Autoimmun Rev       Date:  2016-01-07       Impact factor: 9.754

6.  Host adaptive immunity alters gut microbiota.

Authors:  Husen Zhang; Joshua B Sparks; Saikumar V Karyala; Robert Settlage; Xin M Luo
Journal:  ISME J       Date:  2014-09-12       Impact factor: 10.302

Review 7.  Promises and paradoxes of regulatory T cells in inflammatory bowel disease.

Authors:  James D Lord
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

Review 8.  Microbial tryptophan catabolites in health and disease.

Authors:  Henrik M Roager; Tine R Licht
Journal:  Nat Commun       Date:  2018-08-17       Impact factor: 14.919

9.  The prevalence of MS in the United States: A population-based estimate using health claims data.

Authors:  Mitchell T Wallin; William J Culpepper; Jonathan D Campbell; Lorene M Nelson; Annette Langer-Gould; Ruth Ann Marrie; Gary R Cutter; Wendy E Kaye; Laurie Wagner; Helen Tremlett; Stephen L Buka; Piyameth Dilokthornsakul; Barbara Topol; Lie H Chen; Nicholas G LaRocca
Journal:  Neurology       Date:  2019-02-15       Impact factor: 9.910

10.  Tbet Expression in Regulatory T Cells Is Required to Initiate Th1-Mediated Colitis.

Authors:  Martina Di Giovangiulio; Angelamaria Rizzo; Eleonora Franzè; Flavio Caprioli; Federica Facciotti; Sara Onali; Agnese Favale; Carmine Stolfi; Hans-Joerg Fehling; Giovanni Monteleone; Massimo C Fantini
Journal:  Front Immunol       Date:  2019-09-11       Impact factor: 7.561

View more
  5 in total

Review 1.  Organoid technologies for the study of intestinal microbiota-host interactions.

Authors:  Valentina Bozzetti; Stefania Senger
Journal:  Trends Mol Med       Date:  2022-02-26       Impact factor: 11.951

2.  Ulcerative Colitis in Response to Fecal Microbiota Transplantation via Modulation of Gut Microbiota and Th17/Treg Cell Balance.

Authors:  Chunlan Huang; Qixiang Mei; Lihong Lou; Zehua Huang; Yang Fu; Junjie Fan; Jingjing Wang; Nuoming Yin; Yi Zheng; Yingying Lu; Yue Zeng
Journal:  Cells       Date:  2022-06-05       Impact factor: 7.666

Review 3.  IPEX Syndrome: Genetics and Treatment Options.

Authors:  Iwona Ben-Skowronek
Journal:  Genes (Basel)       Date:  2021-02-24       Impact factor: 4.096

4.  Dysregulation of the Intestinal Microbiome in Patients With Haploinsufficiency of A20.

Authors:  Etsushi Toyofuku; Kozue Takeshita; Hidenori Ohnishi; Yuko Kiridoshi; Hiroaki Masuoka; Tomonori Kadowaki; Ryuta Nishikomori; Kenichi Nishimura; Chie Kobayashi; Takasuke Ebato; Tomonari Shigemura; Yuzaburo Inoue; Wataru Suda; Masahira Hattori; Tomohiro Morio; Kenya Honda; Hirokazu Kanegane
Journal:  Front Cell Infect Microbiol       Date:  2022-01-28       Impact factor: 5.293

Review 5.  Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders - Advances and challenges.

Authors:  Tapas Kumar Goswami; Mithilesh Singh; Manish Dhawan; Saikat Mitra; Talha Bin Emran; Ali A Rabaan; Abbas Al Mutair; Zainab Al Alawi; Saad Alhumaid; Kuldeep Dhama
Journal:  Hum Vaccin Immunother       Date:  2022-03-03       Impact factor: 4.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.